Ayoube Zouak
YOU?
Author Swipe
View article: Study design and rationale for IFCT- 2203 TAXIO: A study that aims to evaluate the effectiveness of a first-line chemotherapy regimen without etoposide, combined with durvalumab, for patients with extensive disease small cell lung cancer
Study design and rationale for IFCT- 2203 TAXIO: A study that aims to evaluate the effectiveness of a first-line chemotherapy regimen without etoposide, combined with durvalumab, for patients with extensive disease small cell lung cancer Open
EU CT: 2023-504670-38-00.
View article: Uncommon EGFR mutations in lung carcinoma: features and treatment outcomes in a retrospective French cohort
Uncommon EGFR mutations in lung carcinoma: features and treatment outcomes in a retrospective French cohort Open
There were variations in treatment outcomes among subgroups in our cohort. Exon 20 insertions showed better ORR and PFS with 1st line chemotherapy compared to TKI. Conversely, other rare EGFR mutations including ECM had better ORR and PFS …